(Q68190284)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1621773%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1621773%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Therapeutic Index of Pilocarpine, Carbachol, and Timolol With Nasolacrimal Occlusion (English)

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)77404-5

16 October 2022

1 reference

1 reference

lacrimal duct obstruction

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1621773

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)77404-5

16 October 2022

author name string

T. J. Zimmerman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1621773

16 October 2022

M. Sharir

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1621773

16 October 2022

G. F. Nardin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1621773

16 October 2022

M. Fuqua

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1621773

16 October 2022

language of work or name

English

0 references

publication date

1 July 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1621773%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

15 July 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1621773

full work available at URL

16 October 2022

https://api.elsevier.com/content/article/PII:S0002939414774045?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)77404-5

https://api.elsevier.com/content/article/PII:S0002939414774045?httpAccept=text/plain

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)77404-5

American Journal of Ophthalmology

16 October 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1621773%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

114

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1621773%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1621773%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

1-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1621773%20AND%20SRC:MED&resulttype=core&format=json

Adverse reactions from timolol administration

22 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Interim report: National Registry of possible Drug-induced Ocular Side Effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Falls in elderly patients with glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Improving the therapeutic index of topically applied ocular drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Ocular Beta-Blockers and Systemic Effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Pilocarpine and intraocular pressure. Duration of effectiveness of 4 percent and 8 percent pilocarpine instillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Dose Response Analysis of Pilocarpine-Induced Ocular Hypotension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Effect of Pilocarpine on Intraocular Pressure in Ocular Hypertensive Subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Timolol, dose response and duration of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Frequency of timolol administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Topical timolol decreases plasma high-density lipoprotein cholesterol level.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

Ocular Bioavailability and Systemic Loss of Topically Applied Ophthalmic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Systemic absorption of topically applied ocular timolol

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2977404-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Effect of pilocarpine drops on the diurnal intraocular pressure variation in patients with glaucoma

11

1 reference

https://api.crossref.org/works/10.1016/S0002-9394(14)77404-5

16 October 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1621773%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference